Neoplastic myelopathy

Seminars in Neurology

Volumn 32, Issue 2, 2012, Pages 137-145

  Nagpal, Seema ^a   Clarke, Jennifer L ^b  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

malignant spinal cord compression; neoplastic myelopathy; spinal cord tumors

Indexed keywords

AMPHIPHYSIN; BEVACIZUMAB; CISPLATIN; CREATININE; CYTARABINE; ETOPOSIDE; GADOLINIUM; HU ANTIBODY; METHOTREXATE; MYELIN BASIC PROTEIN; RITUXIMAB; TEMOZOLOMIDE;

ARTICLE; ASTROCYTOMA; BONE REMODELING; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; EPENDYMOMA; FAMILY HISTORY; HEMANGIOBLASTOMA; HUMAN; LOW DRUG DOSE; MENINGIOMA; NEOPLASTIC MYELOPATHY; NERVE SHEATH TUMOR; NEUROFIBROMA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PILOCYTIC ASTROCYTOMA; POSITRON; PRIORITY JOURNAL; RADIATION DOSE; RADIATION NECROSIS; SPINAL CORD COMPRESSION; SPINAL CORD TUMOR; SURVIVAL RATE; TREATMENT RESPONSE; TUMOR RECURRENCE; VON HIPPEL LINDAU DISEASE;

ANTINEOPLASTIC PROTOCOLS; COMBINED MODALITY THERAPY; HUMANS; SPINAL CORD; SPINAL CORD COMPRESSION; SPINAL NEOPLASMS;

EID: 84865763964     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0032-1322584     Document Type: Article

References (82)

1. Wong DA, Fornasier VL, MacNab I. Spinal metastases: the obvious, the occult, and the impostors. Spine (Phila Pa 1976): 1990; 15 1 1 4
2. Rades D, Abrahm JL. The role of radiotherapy for metastatic epidural spinal cord compression. Nat Rev Clin Oncol: 2010; 7 10 590 598
3. Schellinger KA, Propp JM, Villano JL, McCarthy BJ. Descriptive epidemiology of primary spinal cord tumors. J Neurooncol: 2008; 87 2 173 179
4. Prasad D, Schiff D. Malignant spinal-cord compression. Lancet Oncol: 2005; 6 1 15 24
5. Koeller KK, Rosenblum RS, Morrison AL. Neoplasms of the spinal cord and filum terminale: radiologic-pathologic correlation. Radiographics: 2000; 20 6 1721 1749
6. Schiff D, O'Neill BP, Suman VJ. Spinal epidural metastasis as the initial manifestation of malignancy: clinical features and diagnostic approach. Neurology: 1997; 49 2 452 456
7. Li KC, Poon PY. Sensitivity and specificity of MRI in detecting malignant spinal cord compression and in distinguishing malignant from benign compression fractures of vertebrae. Magn Reson Imaging: 1988; 6 5 547 556
8. Raby N. Cord compression. Imaging: 2009; 21 1 63 77
9. Osborn A. Diagnostic Neuroradiology. Vol 1. First ed. St. Louis, MO Mosby: 1993
10. Cohen-Gadol AA, Zikel OM, Miller GM, Aksamit AJ, Scheithauer BW, Krauss WE. Spinal cord biopsy: a review of 38 cases. Neurosurgery: 2003; 52 4 806 815, discussion 815-816
11. Dillon WP, Norman D, Newton TH, Bolla K, Mark A. Intradural spinal cord lesions: Gd-DTPA-enhanced MR imaging. Radiology: 1989; 170 1 Pt 1 229 237
12. Schweitzer JS, Batzdorf U. Ependymoma of the cauda equina region: diagnosis, treatment, and outcome in 15 patients. Neurosurgery: 1992; 30 2 202 207
13. Karantanis D, O'eill BP, Subramaniam RM., et al. 18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients. Nucl Med Commun: 2007; 28 11 834 841
14. Setzer M, Murtagh RD, Murtagh FR., et al. Diffusion tensor imaging tractography in patients with intramedullary tumors: comparison with intraoperative findings and value for prediction of tumor resectability. J Neurosurg Spine: 2010; 13 3 371 380
15. Vargas MI, Delavelle J, Jlassi H., et al. Clinical applications of diffusion tensor tractography of the spinal cord. Neuroradiology: 2008; 50 1 25 29
16. DeAngelis LM, Posner JB. Neurologic Complications of Cancer. 2nd ed. New York, NY Oxford University Press: 2009
17. Ruff RL, Lanska DJ. Epidural metastases in prospectively evaluated veterans with cancer and back pain. Cancer: 1989; 63 11 2234 2241
18. Siegal T. Spinal cord compression: from laboratory to clinic. Eur J Cancer: 1995; 31A 11 1748 1753
19. Vecht CJ, Haaxma-Reiche H, van Putten WL, de Visser M, Vries EP, Twijnstra A. Initial bolus of conventional versus high-dose dexamethasone in metastatic spinal cord compression. Neurology: 1989; 39 9 1255 1257
20. Heimdal K, Hirschberg H, Slettebo H, Watne K, Nome O. High incidence of serious side effects of high-dose dexamethasone treatment in patients with epidural spinal cord compression. J Neurooncol: 1992; 12 2 141 144
21. Patchell RA, Tibbs PA, Regine WF., et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet: 2005; 366 9486 643 648
22. George R, Jeba J, Ramkumar G, Chacko AG, Leng M, Tharyan P. Interventions for the treatment of metastatic extradural spinal cord compression in adults. Cochrane Database Syst Rev: 2008; 4 CD006716
23. Gerszten PC, Mendel E, Yamada Y. Radiotherapy and radiosurgery for metastatic spine disease: what are the options, indications, and outcomes? Spine (Phila Pa 1976): 2009; 34 22, Suppl S78 S92
24. Maiuri F, De Caro ML, de Divitiis O, Vergara P, Mariniello G. Spinal meningiomas: age-related features. Clin Neurol Neurosurg: 2011; 113 1 34 38
25. Cohen-Gadol AA, Zikel OM, Koch CA, Scheithauer BW, Krauss WE. Spinal meningiomas in patients younger than 50 years of age: a 21-year experience. J Neurosurg: 2003; 98 3 Suppl 258 263
26. Solero CL, Fornari M, Giombini S., et al. Spinal meningiomas: review of 174 operated cases. Neurosurgery: 1989; 25 2 153 160
27. Sade B, Chahlavi A, Krishnaney A, Nagel S, Choi E, Lee JH. World Health Organization Grades II and III meningiomas are rare in the cranial base and spine. Neurosurgery: 2007; 61 6 1194 1198, discussion 1198
28. Jo K, Park HJ, Nam DH., et al. Treatment of atypical meningioma. J Clin Neurosci: 2010; 17 11 1362 1366
29. Guideline Version NCCN 2.2011 for Central Nervous System Cancers. National Comprehensive Cancer Network 2011. Available at: http://www.nccn.org/ professionals/physician-gls/f-guidelines.asp. Accessed February 15, 2011
30. Chamberlain MC, Glantz MJ, Fadul CE. Recurrent meningioma: salvage therapy with long-acting somatostatin analogue. Neurology: 2007; 69 10 969 973
31. Grimm SA, Chamberlain MC, Chandler J., et al. A Phase II Trial of PTK787/ZK 222584 (PTK787) in recurrent high-grade meningioma. J Clin Oncol 29: 2011 (suppl):abstr 2046
32. Wen PY, Yung WK, Lamborn KR., et al. Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08). Neuro-oncol: 2009; 11 6 853 860
33. Kaley TJ, Wen P, Karimi S, Lieberman F, Schiff D, Abrey L. Phase II Trial of Sunitinib (SU011248) for recurrent or inoperable meningioma. Paper presented at: 13th Annual Meeting of the Society for Neuro Oncology; November 20-23, 2008; Las Vegas, NV
34. Conti P, Pansini G, Mouchaty H, Capuano C, Conti R. Spinal neurinomas: retrospective analysis and long-term outcome of 179 consecutively operated cases and review of the literature. Surg Neurol: 2004; 61 1 34 43, discussion 44
35. Gerszten PC, Ozhasoglu C, Burton SA, Kalnicki S, Welch WC. Feasibility of frameless single-fraction stereotactic radiosurgery for spinal lesions. Neurosurg Focus: 2002; 13 4 e2
36. Murovic JA, Gibbs IC, Chang SD, Mobley BC, Park J, Adler JR Jr. Foraminal nerve sheath tumors: intermediate follow-up after cyberknife radiosurgery. Neurosurgery: 2009; 64 2, Suppl A33 A43
37. Evans DG, Birch JM, Ramsden RT, Sharif S, Baser ME. Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes. J Med Genet: 2006; 43 4 289 294
38. Anghileri M, Miceli R, Fiore M., et al. Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution. Cancer: 2006; 107 5 1065 1074
39. Helseth A, Mork SJ. Primary intraspinal neoplasms in Norway, 1955 to 1986. A population-based survey of 467 patients. J Neurosurg: 1989; 71 6 842 845
40. Milano MT, Johnson MD, Sul J., et al. Primary spinal cord glioma: a surveillance, epidemiology, and end results database study. J Neurooncol: 2010; 98 1 83 92
41. Schiff D, O'Neill BP. Intramedullary spinal cord metastases: clinical features and treatment outcome. Neurology: 1996; 47 4 906 912
42. Harrop JS, Ganju A, Groff M, Bilsky M. Primary intramedullary tumors of the spinal cord. Spine (Phila Pa 1976): 2009; 34 22, Suppl S69 S77
43. McGuire CS, Sainani KL, Fisher PG. Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study. J Neurosurg: 2009; 110 4 725 729
44. Kurimoto M, Nagai S, Hamada H., et al. Malignant transformation of supratentorial clear cell ependymoma. Neuropathology: 2009; 29 3 299 302
45. Reni M, Gatta G, Mazza E, Vecht C. Ependymoma. Crit Rev Oncol Hematol: 2007; 63 1 81 89
46. Yang S, Yang X, Hong G. Surgical treatment of one hundred seventy-four intramedullary spinal cord tumors. Spine (Phila Pa 1976): 2009; 34 24 2705 2710
47. Halvorsen CM, Kolstad F, Hald J., et al. Long-term outcome after resection of intraspinal ependymomas: report of 86 consecutive cases. Neurosurgery: 2010; 67 6 1622 1631, discussion 1631
48. Waldron JN, Laperriere NJ, Jaakkimainen L., et al. Spinal cord ependymomas: a retrospective analysis of 59 cases. Int J Radiat Oncol Biol Phys: 1993; 27 2 223 229
49. Volpp PB, Han K, Kagan AR, Tome M. Outcomes in treatment for intradural spinal cord ependymomas. Int J Radiat Oncol Biol Phys: 2007; 69 4 1199 1204
50. Schild SE, Nisi K, Scheithauer BW., et al. The results of radiotherapy for ependymomas: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys: 1998; 42 5 953 958
51. Vanuytsel L, Brada M. The role of prophylactic spinal irradiation in localized intracranial ependymoma. Int J Radiat Oncol Biol Phys: 1991; 21 3 825 830
52. Guidetti B. Intramedullary tumours of the spinal cord. Acta Neurochir (Wien): 1967; 17 1 7 23
53. Wahab SH, Simpson JR, Michalski JM, Mansur DB. Long term outcome with post-operative radiation therapy for spinal canal ependymoma. J Neurooncol: 2007; 83 1 85 89
54. Gomez DR, Missett BT, Wara WM., et al. High failure rate in spinal ependymomas with long-term follow-up. Neuro-oncol: 2005; 7 3 254 259
55. Chamberlain MC, Johnston SK. Temozolomide for recurrent intracranial supratentorial platinum-refractory ependymoma. Cancer: 2009; 115 20 4775 4782
56. Bouffet E, Capra M, Bartels U. Salvage chemotherapy for metastatic and recurrent ependymoma of childhood. Childs Nerv Syst: 2009; 25 10 1293 1301
57. Chamberlain MC. Salvage chemotherapy for recurrent spinal cord ependymona. Cancer: 2002; 95 5 997 1002
58. Sandri A, Massimino M, Mastrodicasa L., et al. Treatment with oral etoposide for childhood recurrent ependymomas. J Pediatr Hematol Oncol: 2005; 27 9 486 490
59. Green RM, Cloughesy TF, Stupp R., et al. Bevacizumab for recurrent ependymoma. Neurology: 2009; 73 20 1677 1680
60. Epstein FJ, Farmer JP, Freed D. Adult intramedullary astrocytomas of the spinal cord. J Neurosurg: 1992; 77 3 355 359
61. Garcés-Ambrossi GL, McGirt MJ, Mehta VA., et al. Factors associated with progression-free survival and long-term neurological outcome after resection of intramedullary spinal cord tumors: analysis of 101 consecutive cases. J Neurosurg Spine: 2009; 11 5 591 599
62. Fernandez C, Figarella-Branger D, Girard N., et al. Pilocytic astrocytomas in children: prognostic factorsa retrospective study of 80 cases. Neurosurgery: 2003; 53 3 544 553, discussion 554-555
63. Eroes CA, Zausinger S, Kreth FW, Goldbrunner R, Tonn JC. Intramedullary low grade astrocytoma and ependymoma. Surgical results and predicting factors for clinical outcome. Acta Neurochir (Wien): 2010; 152 4 611 618
64. Abdel-Wahab M, Etuk B, Palermo J., et al. Spinal cord gliomas: A multi-institutional retrospective analysis. Int J Radiat Oncol Biol Phys: 2006; 64 4 1060 1071
65. Minehan KJ, Brown PD, Scheithauer BW, Krauss WE, Wright MP. Prognosis and treatment of spinal cord astrocytoma. Int J Radiat Oncol Biol Phys: 2009; 73 3 727 733
66. Massimino M, Spreafico F, Riva D., et al. A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood progressive low-grade glioma. J Neurooncol: 2010; 100 1 65 71
67. Chamberlain MC. Temozolomide for recurrent low-grade spinal cord gliomas in adults. Cancer: 2008; 113 5 1019 1024
68. Chamberlain MC, Johnston SK. Recurrent spinal cord glioblastoma: salvage therapy with bevacizumab. J Neurooncol: 2011; 102 3 427 432
69. Tago M, Terahara A, Shin M., et al. Gamma knife surgery for hemangioblastomas. J Neurosurg: 2005; 102 Suppl 171 174
70. National Cancer Institute Non Hodgkin Lymphoma. PDQ Adult Non Hodgkin Lymphoma. 2010;. Available at: http://www.cancer.gov/cancertopics/types/non- hodgkin. Accessed January 26, 2011
71. Central Brain Tumor Registry of the United States (CBTRUS) Statistical Report CBTRUS. Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2007. 2010;. Available at: http://www.cbtrus.org Accessed March 1, 2011
72. Bekar A, Cordan T, Evrensel T, Tolunay S. A case of primary spinal intramedullary lymphoma. Surg Neurol: 2001; 55 5 261 264
73. Machiya T, Yoshita M, Iwasa K, Yamada M. Primary spinal intramedullary lymphoma mimicking ependymoma. Neurology: 2007; 68 11 872
74. Nieder C, Ataman F, Price RE, Ang KK. Radiation myelopathy: new perspective on an old problem. Radiat Oncol Investig: 1999; 7 4 193 203
75. van der Kogel A. Radiation response and tolerance of normal tissues. In: Steele GG. ed. Basic Clinical Radiobiology. London Arnold: 1997; 30 39
76. Levin VA, Bidaut L, Hou P., et al. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys: 2011; 79 5 1487 1495
77. Watterson J, Toogood I, Nieder M., et al. Excessive spinal cord toxicity from intensive central nervous system-directed therapies. Cancer: 1994; 74 11 3034 3041
78. Gangji D, Reaman GH, Cohen SR, Bleyer WA, Poplack DG. Leukoencephalopathy and elevated levels of myelin basic protein in the cerebrospinal fluid of patients with acute lymphoblastic leukemia. N Engl J Med: 1980; 303 1 19 21
79. Dalmau JRM. Paraneoplastic syndromes affecting the spinal cord and dorsal root ganglia. UpToDate 2010; Review Article. Available at: http://www.uptodate. com. Accessed July 21, 2012
80. Harrop JS, Schmidt MH, Boriani S, Shaffrey CI. Aggressive "benigno" primary spine neoplasms: osteoblastoma, aneurysmal bone cyst, and giant cell tumor. Spine (Phila Pa 1976): 2009; 34 22, Suppl S39 S47
81. Wang VY, Potts M, Chou D. Sarcoma and the spinal column. Neurosurg Clin N Am: 2008; 19 1 71 80
82. Yamazaki T, McLoughlin GS, Patel S, Rhines LD, Fourney DR. Feasibility and safety of en bloc resection for primary spine tumors: a systematic review by the Spine Oncology Study Group. Spine (Phila Pa 1976): 2009; 34 22, Suppl S31 S38